Search

Search Constraints

You searched for: Author/Creator Mol, L.

Search Results

1. 1217 EORTC QLQ-C30 for cost-effectiveness research in metastatic colorectal cancer patients (mCRC): Design and validation of a mapping algorithm. (September 2015)

2. 2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis. (September 2015)

4. Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer. (April 2017)

5. Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group. (February 2017)